Atherosclerotic Cardiovascular Disease Clinical Trials
2 recruiting trials for Atherosclerotic Cardiovascular Disease. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 2 / Phase 3NCT05485961
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a dose-finding study for CSL300 vs...
Sponsor: CSL BehringEnrolling: 231020 locations
RECRUITINGNCT06541691
Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic...
Although both enteric-coated and plain formulations of aspirin are being used commonly, there are no high-quality comparisons between these formulations with respect to clinical...
Sponsor: Rajaie Cardiovascular Medical and Research CenterEnrolling: 30001 location